Sustain-release lipid-liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL/6 mice
The Gram-negative bacterium Helicobacter pylori, H. pylori, is associated with significant digestive disorders. However, the effectiveness of bacterial eradication is declining due to drug resistance. A potent an...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Kiarash Ghazvini, Hossein Kamali, Hadi Farsiani, Masoud Yousefi and Masoud Keikha Tags: Research Source Type: research
More News: Drugs & Pharmacology | Helicobacter Pylori